OPEN PloS one | 11 Jun 2015
NH Shah, P LePendu, A Bauer-Mehren, YT Ghebremariam, SV Iyer, J Marcus, KT Nead, JP Cooke and NJ Leeper
Proton pump inhibitors (PPIs) have been associated with adverse clinical outcomes amongst clopidogrel users after an acute coronary syndrome. Recent pre-clinical results suggest that this risk might extend to subjects without any prior history of cardiovascular disease. We explore this potential risk in the general population via data-mining approaches.
* Data courtesy of Altmetric.com